Pharma's Almanac TV
PA TV
Follow the Completed Journey
Companies We've Met
AES Clean Technology
Altis Biosystems
Arranta Bio
Avara Pharmaceutical Services
Avid Bioservices
BioVectra
Centaur BPS
Dynamk Capital
ECRI
Evolve Biologics
Federal Equipment Company
Globyz
Inceptor Bio
IPS-Integrated Project Services
Olon
Pii
Polpharma Biologics
PPD
RoosterBio
SanaClis
Sanofi AIS
SGD Pharma
SPI Pharma
TriRx Pharmaceutical Services
Yourway
Follow the Journey
Companies On The Road
Follow The Artist
aCGT Vector
Alconox Inc.
Andelyn Biosciences
Arranta Bio
Avid Bioservices
BDD
BIOVECTRA
DPS Group
Dynamk Capital
Environmental Systems Corporation
Federal Equipment Company
Genesis AEC
Globyz Biopharma Services
Grifols Partnership
IDT Biologika
Inceptor Bio
IPS-Integrated Project Services
Kineticos
MilliporeSigma
Montana BioScience Alliance
Olon
Rentschler Biopharma
SanaClis
Scorpion Biological Services
Secant Group
Tapemark
VITRONIC
Dashboard
Your Name
Your Email
Manage Account
Sign Out
Sign In
Register
Topics
Products
ADC
API - Small Molecule
Biologics
Biopharmaceuticals
Biosimilars
Cell and Gene Therapy
DNA
Drug Product
Drug Substance
Equipment
Generics
Immunotherapy
Injectables
Monoclonal Antibody
Novel Therapeutics
Oral Solid Dosage
Orphan Drugs
Parenterals
Stem Cells
Vaccine
Services
Big Data
Bioprocessing
Clinical Trials
Continuous Manufacturing
Diagnostics
Drug Delivery
Drug Development
Drug Discovery
Facility
Formulation
Innovation
Oncology
Patient Adherence
Patient Centric
Preclinical
Process Development
Quality
Regulatory
Research
Serialization
Segment
Biomanufacturing
Biotechnology
CDMO
Consulting
CRO
Engineering
Equipment
Excipients
Healthcare
Intermediates
Logistics
Manufacturing
Packaging
Supply Chain
Business
Agreement
Appointment
Business
Capacity Expansion
Collaboration
Growth
Investment
Licensing
M&A
Market Expansion
Market Intelligence
Market Prediction
New Facility
Strategic Partnership
Magazine
Archive
Reports
2021 Cell & Gene Therapy Report
2021 Monoclonal Antibody & Recombinant Protein Market Report
2021 Sterile Drug Market Report
2021 API Market Report
2020 OSD Market Report
Community
Company A to Z
Follow the Journey
Companies On The Road
Follow The Artist
More+
Staffing
Media Kit
MilliporeSigma
Articles Available
Can't find what you're looking for? Try our
advanced search
.
Gene Therapy
Pandemic Playbook for Gene Therapy Manufacturing
PAO-09-21-CL-14
Tablet Coating
An Easy-to-Use Tablet Coating Polymer to Increase Coating Process Efficiency and Flexibility
PAO-09-21-CL-06
3D Printing
Transferring 3D Printing into Pharma: The Journey Has Begun
PAO-07-21-CL-04
eData Exchange
Innovating to Realize the Benefits of Data Sharing
PAO-06-21-CL-13
Antibody-Drug Conjugates
Accelerating ADC Development with Advanced Payload Intermediates
PAO-06-21-CL-11
Biocompatibility
Championing In Vitro Biocompatibility/Biological Reactivity Testing for Plastics Used in Pharma Manufacturing
PAO-06-21-CL-09
mRNA Therapies
Realizing the Promise of RNA Therapies with Lipid Nanoparticle Delivery
PAO-06-21-CL-08
Viral Inactivation
Continuous Inline Viral Inactivation for Next-Generation Bioprocessing
PAO-05-21-CL-06
MilliporeSigma Announces VectorY as Winner of its Advance Biotech Grant
PR-M05-21-015
Cell and Gene Therapy
Reducing the Risk During Cell and Gene Therapy Development and Manufacturing
PAO-03-21-CL-9
Gene Therapy
Avoiding Costly And Time-Consuming Mistakes In Gene Therapy Process Development
PAO-03-21-CL-08
Biopharmaceutical Manufacturing
Bridging the Biopharmaceutical Manufacturing Digital Divide
PAO-03-21-CL-04
Process Intensification
Factory of the Future Will Be a Convergence of Digital and Bioprocessing Technologies
PAO-02-21-CL-03
Nitrosamine
Supporting Drug Manufacturers with Emprove® Nitrosamine Declarations
PAO-02021-CL-05
Gene Therapy
Beyond 2020: Looking into the Crystal Ball for Gene Therapy
PAO-01-21-CL-03
Hot Melt Extrusion
Solving Solubility Challenges with a Polyvinyl Alcohol Excipient and Hot Melt Extrusion
PAP-Q4-20-CL-016
Extractables & Leachables
Aiding Material Qualification and Risk Assessment for Single-Use Biomanufacturing
PAP-Q4-20-CL-015
Antibody–Drug Conjugates
Preparing for the ADC Explosion with End-to-End Support
PAP-Q4-20-CL-014
Gene Therapy
Anticipating the Next Decade of Gene Therapy
PAO-11-20-CL-02
Orally Disintegrating Tablets
Qualifying ODT Excipient Systems Beyond Disintegration Performance
PAO-10-20-CL-03
Wet Granulation
The Application of Mannitol In Wet Granulation
PAO-10-20-CL-01
Lipid Excipients
Successful Drug Development with Synthetic Lipids: Critical Aspects and Strategies
PAP-Q3-20-CL-024
Clinical Trials
Celyad Oncology Announces Clinical Trial Collaboration to Evaluate CYAD-101 with KEYTRUDA
PR-M09-20-32
Expansion
MilliporeSigma Announces $65 Million Antibody-Drug Conjugate Manufacturing Expansion
PR-M09-20-NI-14
